ArticlePolymers2025
4-Iodobenzonitrile as Effective Solid Additive for High-Efficiency Polymer Solar Cells.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Solid additive engineering is a well-established and effective strategy for enhancing active layer morphology in polymer solar cells (PSCs), thereby improving their power conversion efficiency (PCE). However, the availability of effective solid additive molecules remains limited, especially those combining simple structural units with a large dipole moment to promote strong interactions with active materials. In this study, we introduce 4-iodobenzonitrile (IBZN), a commercially available, low-cost, and structurally simple molecule with a high dipole moment (3.33 debye), as a solid additive for PSCs. Theoretical calculations, ultraviolet-visible (UV-Vis) spectroscopy experiments, and a morphology analysis demonstrate that IBZN forms strong interactions with L8-BO, subsequently enhancing the packing mode and crystallization. The incorporation of IBZN into PM6:L8-BO-based PSCs resulted in an increased fill factor (FF) of 79.54% and a boosted PCE from 17.49% to 18.77%. Furthermore, IBZN has also demonstrated outstanding regulatory effects in systems based on other Y-series acceptors, such as Y6 and BTP-ec9. This study not only introduces a structurally simple solid additive molecule characterized by a large dipole moment but also offers valuable insights for the subsequent development of novel solid additives aimed at enhancing the morphology and efficiency of PSCs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.